Leap Therapeutics Inc. (LPTX)
NASDAQ: LPTX
· Real-Time Price · USD
0.42
0.03 (6.87%)
At close: Jun 09, 2025, 3:59 PM
Leap Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.44M | -15.43M | -18.18M | -20.13M | -13.82M | -12.46M | -13.7M | -13.39M | -41.86M | -12.1M | -15.09M | -17.02M | -10.38M | -10.79M | -11.14M | -9.53M | -9.13M |
Depreciation & Amortization | n/a | n/a | -202K | 202K | 5K | 110K | -199K | 106K | 104K | 4K | 4K | 4K | 4K | 8K | 7K | -88K | 102K |
Stock-Based Compensation | 1.2M | 1.55M | 1.34M | 1.37M | 1.25M | 1.25M | 1.3M | 1.26M | 1.31M | 1.46M | 1.25M | 1.27M | 1.2M | 938K | 1M | 708K | 833K |
Other Working Capital | n/a | -396K | -2.51M | 169K | -432K | -1.89M | 70K | 122K | 2.2M | -2.72M | -1.23M | 1.98M | 149K | -4.95M | 1.71M | 800K | -830K |
Other Non-Cash Items | n/a | 439K | 3.57M | -106K | 4.01M | -439K | 306K | 195K | 29.84M | -752K | 903K | 835K | -131K | 167K | 59K | 225K | 34K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -501K | 501K | n/a | n/a | 152K | n/a | n/a | n/a | 11K | 260K | 129K | 21K |
Change in Working Capital | n/a | -2.07M | -2.13M | 4.99M | -3.06M | 1.66M | 1.3M | 1.64M | -2.09M | -1.77M | 681K | 2.66M | -2.22M | -1.05M | 1.71M | 800K | -443K |
Operating Cash Flow | -14.48M | -15.51M | -15.6M | -13.67M | -15.52M | -10.38M | -10.49M | -10.19M | -12.7M | -13.01M | -12.25M | -12.26M | -11.52M | -10.72M | -8.1M | -7.75M | -8.59M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -100.72M | n/a | 50.36M | 50.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -50.71M | -1.04M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | -100.72M | n/a | -348K | 49.32M | 210K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -61K | 104K | -66K | 37.12M | 29K | n/a | -1K | n/a | -29K | n/a | n/a | n/a | -210K | 755K | 40K | 4K | 14K |
Financial Cash Flow | -61K | 104K | -66K | 37.12M | 29K | n/a | -1K | n/a | -29K | n/a | n/a | n/a | -210K | 755K | 97.26M | 4K | 14K |
Net Cash Flow | -14.54M | -15.57M | -15.66M | 23.56M | -15.72M | -10.1M | -10.67M | -10.62M | 36.54M | -12.81M | -12.57M | -12.34M | -11.7M | -9.86M | 89.04M | -7.76M | -8.58M |
Free Cash Flow | -14.48M | -15.51M | -15.6M | -13.67M | -15.52M | -10.38M | -10.49M | -10.19M | -12.7M | -13.01M | -12.25M | -12.26M | -11.52M | -10.72M | -8.1M | -7.75M | -8.59M |